Roland E Kontermann

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 17

Top Topics

Tyrosine Kinase

Epidermal Growth Factor Receptor

Top Venues

Molecules (Basel, Switzerland)

Journal for immunotherapy of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Lennart Kühl, Annelie K Schäfer, Sebastian Kraft, Nadine Beha, Roland E Kontermann, Oliver Seifert
eIg-based bispecific T-cell engagers targeting EGFR: Format matters. mAbs 15 (1) (2023)
Lennart Kühl, Annelie K Schäfer, Sebastian Kraft, Nadine Beha, Roland E Kontermann, Oliver Seifert
eIg-based bispecific T-cell engagers targeting EGFR: Format matters. mAbs 15 (1) (2023)
Lennart Kühl, Annelie K Schäfer, Sebastian Kraft, Nadine Beha, Roland E Kontermann, Oliver Seifert
eIg-based bispecific T-cell engagers targeting EGFR: Format matters. mAbs 15 (1) (2023)
Lennart Kühl, Annelie K Schäfer, Sebastian Kraft, Nadine Beha, Roland E Kontermann, Oliver Seifert
eIg-based bispecific T-cell engagers targeting EGFR: Format matters. mAbs 15 (1) (2023)
Lennart Kühl, Nadine Beha, Roland E Kontermann, Oliver Seifert
The eIg technology to generate Ig-like bispecific antibodies. mAbs 14 (1) (2022)
Nadine Beha, Katharina Kocher, Martin Siegemund, Martina S Lutz, Lennart Kühl, Oliver Seifert, Roland E Kontermann
Fc-based Duokines: dual-acting costimulatory molecules comprising TNFSF ligands in the single-chain format fused to a heterodimerizing Fc (scDk-Fc). Oncoimmunology 11 (1) (2022)
Oliver Seifert, Roland E Kontermann
GlycoTAIL and FlexiTAIL as Half-Life Extension Modules for Recombinant Antibody Fragments. Molecules (Basel, Switzerland) 27 (10) (2022)
Roland E Kontermann, Guy Ungerechts, Dirk M Nettelbeck
Viro-antibody therapy: engineering oncolytic viruses for genetic delivery of diverse antibody-based biotherapeutics. mAbs 13 (1) (2022)
Alexander Rau, Katharina Kocher, Mirjam Rommel, Lennart Kühl, Maximilian Albrecht, Hannes Gotthard, Nadine Beha, Bettina Noll, Monilola A Olayioye, Roland E Kontermann, Oliver Seifert
A bivalent, bispecific Dab-Fc antibody molecule for dual targeting of HER2 and HER3. mAbs 13 (1) (2022)
Nadine Aschmoneit, Lennart Kühl, Oliver Seifert, Roland E Kontermann
Fc-comprising scDb-based trivalent, bispecific T-cell engagers for selective killing of HER3-expressing cancer cells independent of cytokine release. Journal for immunotherapy of cancer 9 (11) (2022)
Christian Jost, Diana Darowski, John Challier, Vesna Pulko, Lydia J Hanisch, Wei Xu, Ekkehard Mössner, Alexander Bujotzek, Stefan Klostermann, Pablo Umana, Roland E Kontermann, Christiane Neumann
CAR-J cells for antibody discovery and lead optimization of TCR-like immunoglobulins. mAbs 12 (1) (2021)
Oliver Seifert, Alexander Rau, Nadine Beha, Fabian Richter, Roland E Kontermann
Diabody-Ig: a novel platform for the generation of multivalent and multispecific antibody molecules. mAbs 11 (5) (2019)
Fabian Richter, Oliver Seifert, Andreas Herrmann, Klaus Pfizenmaier, Roland E Kontermann
Improved monovalent TNF receptor 1-selective inhibitor with novel heterodimerizing Fc. mAbs 11 (4) (2019)
Alessandro Satta, Mezzanzanica Delia, Francesco Caroli, Barbara Frigerio, Massimo Di Nicola, Roland E Kontermann, Federico Iacovelli, Alessandro Desideri, Silvana Canevari, Alessandro Massimo Gianni
Design, selection and optimization of an anti-TRAIL-R2/anti-CD3 bispecific antibody able to educate T cells to recognize and destroy cancer cells. mAbs 10 (7) (2018)
Fabian Richter, Kirstin A Zettlitz, Oliver Seifert, Andreas Herrmann, Peter Scheurich, Klaus Pfizenmaier, Roland E Kontermann
Monovalent TNF receptor 1-selective antibody with improved affinity and neutralizing activity. mAbs 11 (1) (2018)
Sina Fellermeier-Kopf, Friederike Gieseke, Ugur Sahin, Dafne Müller, Klaus Pfizenmaier, Roland E Kontermann
Duokines: a novel class of dual-acting co-stimulatory molecules acting in cis or trans. Oncoimmunology 7 (9) (2018)
Lisa C Schmitt, Alexander Rau, Oliver Seifert, Jonas Honer, Meike Hutt, Simone Schmid, Jonas Zantow, Michael Hust, Stefan Dübel, Monilola A Olayioye, Roland E Kontermann
Inhibition of HER3 activation and tumor growth with a human antibody binding to a conserved epitope formed by domain III and IV. mAbs 9 (5) (2017)